Company Search:
Advanced Search
Sponsored Links
Cellectis SA Company Snapshot
Cellectis SA operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Cellectis SA with three other companies in this sector in France: Eurofins-Cerep SA (2016 sales of 23.44 million Euro [US$29.19 million] ), Adocia SAS (22.49 million Euro [US$28.00 million] of which 100% was Regenerative Medicine), and Innate Pharma S.A. (56.16 million Euro [US$69.94 million] of which 100% was Licensing Revenue).

Sales Analysis. Cellectis SA reported sales of 51.01 million Euro (US$63.52 million) for the year ending December of 2016. This represents a decrease of 9.5% versus 2015, when the company's sales were 56.39 million Euro. Contributing to the drop in overall sales was the 6.0% decline in Therapeutics, from 57.14 million Euro to 53.73 million Euro. . However, these declines were partially offset by the increase in sales of Plants (up 1,370.5% to 647,000.00 Euro) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Cellectis SA
  Stock Performance Chart for Cellectis SA
  Stock Data: Recent Stock Performance:
  Current Price (2/16/2018): 26.40
(Figures in Euro)
1 Week 12.3%   13 Weeks 9.5%  
4 Weeks 32.4%   52 Weeks 26.0%  
Cellectis SA Key Data:
  Ticker: ALCLS Country: France
  Exchanges: PAR Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 51,007,000
(Year Ending Jan 2017).
Employees: 89
  Currency: Euro Market Cap: 945,211,608
  Fiscal Yr Ends: December Shares Outstanding: 35,803,470
  Share Type: Action Ordinaires Closely Held Shares: 3,354,944
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.